Ovid Therapeutics (OVID) Stock Price

$0.618 0%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    1

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Ovid Therapeutics, AI stock picks, stock alerts and much more.

Sign up

OVID AI Stock Analysis

AI stock analysis for OVID is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Ovid Therapeutics (OVID) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Ovid Therapeutics (OVID) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Ovid Therapeutics (OVID), currently trading at $0.618, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About OVID

LSE

  • Ovid Therapeutics Inc.

  • Symbol

    OVID

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    43.8M

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates

Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates
November 12, 2024. zacks.com

OVID Alternative Data

Web Traffic

Ovid Therapeutics receives an estimated 4980 monthly visitors to ovidrx.com.

  • Web Traffic

    4980

  • Change from Previous Month

    17.1%

  • 3 Month Change

    111.6%

  • YoY Change

    111.6%

News Mentions

Ovid Therapeutics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

Reddit Mentions

Ovid Therapeutics has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    1

  • Daily Change

    0%

Twitter Followers

Ovid Therapeutics has 1,574 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.

  • Twitter Followers

    1574

  • Daily Change

    0.1%

  • 1 Month Change

    0.1%

  • 3 Month Change

    1.5%

  • YoY Change

    1.5%

Facebook Engagement

Ovid Therapeutics has engaged 2 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    2

  • Daily Change

    100%

  • 1 Month Change

    100%

  • 3 Month Change

    77.8%

  • YoY Change

    77.8%

Instagram Followers

Ovid Therapeutics has 593 Instagram Followers on its main Instagram account, up by 0.9% over the last month.

  • Instagram Followers

    593

  • Daily Change

    0.3%

  • 1 Month Change

    0.9%

  • 3 Month Change

    2.6%

  • YoY Change

    2.6%

Youtube Subscribers

Ovid Therapeutics has 523 subscribers on its main Youtube channel.

  • Youtube Subscribers

    523

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.2%

  • YoY Change

    0.2%

LinkedIn Followers

17,393 are following Ovid Therapeutics on LinkedIn, up by 1% over the last month.

  • LinkedIn Followers

    17393

  • Daily Change

    0.1%

  • 1 Month Change

    1%

  • 3 Month Change

    2.4%

Job Postings

Ovid Therapeutics currenly has an estimated 1 open job postings.

  • Job Postings

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Ovid Therapeutics has 43 employees, up by 4.9% over the last month.

  • LinkedIn Employees

    43

  • Daily Change

    0%

  • 1 Month Change

    4.9%

  • 3 Month Change

    4.4%

  • YoY Change

    4.4%

Business Outlook

  • Business Outlook

    52

  • Change from Previous Month

    1.9%

  • 3 Month Change

    0%

  • YoY Change

    0%

OVID Financials

OVID Key Metrics

  • Total Revenue

    $173K

  • Net Income

    -$14M

  • Earnings per Share

    -$0.2

  • Free cash flow

    -$15M

  • EBITDA

    -$13.1M

  • EBITDA Ratio

    -75.474

  • Total Assets

    $102.7M

OVID 2-year Revenue & Income
OVID 2-year Free Cash Flow

OVID Technicals

OVID SMA
OVID RSI

FAQ

What's the current price of Ovid Therapeutics (OVID) Stock?
The price of an Ovid Therapeutics (OVID) share is $0.618.

What's the market cap of Ovid Therapeutics?
The current market cap of Ovid Therapeutics is 43.8M.

Should I buy or sell OVID?
Ovid Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Ovid Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.

Is Ovid Therapeutics a good investment?
The current analysis of Ovid Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Ovid Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Ovid Therapeutics (OVID) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Ovid Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Ovid Therapeutics (OVID) that investors often compare it to?
Ovid Therapeutics (OVID) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Ovid Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Ovid Therapeutics' stock price to be around $0.594 in 2026. Starting from the current price of $0.618, this represents a 3.9% change in price, indicating a neutral outlook for the stock.

How to buy Ovid Therapeutics (OVID) Stock?
Ovid Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Ovid Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.